Cup and HandleThis is not to long entry level yet.
Possible stop under handle low.
No recommendation
−1.02USD
−74.40 MUSD
361.05 MUSD
73.81 M
About Veracyte, Inc.
Sector
Industry
CEO
Marc A. Stapley
Website
Headquarters
South San Francisco
Employees (FY)
815
Founded
2006
ISIN
US92337F1075
FIGI
BBG001J2M542
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Veracyte, verily so. VCYTX Wave, we are going up to a point.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fra
VCYTThey may have reached the bottom, as well as the entire XBI sector. Although it may still decrease to the red trend. Presumably the lateral correction is over.
Comment: One fibo taking into account the logarithm, the other without.
just now
Comment: One of the few biotech companies that I am inter
+22% profit on $VCYT after it broke the triangle .Perfect breakout and it hit triangle target by penny :) . It has more room to move up but it needs a pullback to the upper triangle channel .
VCYT - potential reboundAfter a correction of more than 27% from the previous peak, it's showing a sign of rebound. Short term target at 51.43 after confirmation at 48.95.
It's good to know the advancement oft $VCYT in lung cancer detection and collaboration with $JNJ .
VCVT on huge dip. Retracement shows a possibly bounce off of $45 then heading back up in which a long entry for quick swing can work. If it does not hold $45 it will continue down to low $30's possible final bottom at $28.
VCYT stock analysis Support and resistance areas
Expect me not to post too often I’ve been a tad busy
VCYT analysis number 2Support and resistance areas after the false breakout,I will buy if there is a close over the red area
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VCYT is 18.86 USD — it has decreased by 0.32% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Veracyte, Inc. stocks are traded under the ticker VCYT.
Veracyte, Inc. is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
VCYT stock is 3.20% volatile and has beta coefficient of 2.72. Check out the list of the most volatile stocks — is Veracyte, Inc. there?
One year price forecast for Veracyte, Inc. has a max estimate of 37.00 USD and a min estimate of 21.00 USD.
VCYT earnings for the last quarter are −0.41 USD whereas the estimation was −0.15 USD which accounts for −179.89% surprise. Estimated earnings for the next quarter are −0.10 USD. See more details about Veracyte, Inc. earnings.
Veracyte, Inc. revenue for the last quarter amounts to 90.11 M USD despite the estimated figure of 84.36 M USD. In the next quarter revenue is expected to reach 91.97 M USD.
Yes, you can track Veracyte, Inc. financials in yearly and quarterly reports right on TradingView.
VCYT stock has fallen by 5.04% compared to the previous week, the month change is a 10.53% fall, over the last year Veracyte, Inc. has showed a 18.60% decrease.
VCYT net income for the last quarter is −28.29 M USD, while the quarter before that showed −29.62 M USD of net income which accounts for 4.47% change. Track more Veracyte, Inc. financial stats to get the full picture.
Today Veracyte, Inc. has the market capitalization of 1.42 B, it has increased by 0.88% over the last week.
No, VCYT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VCYT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Veracyte, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 815.00 employees. See our rating of the largest employees — is Veracyte, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Veracyte, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Veracyte, Inc. stock shows the strong sell signal. See more of Veracyte, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Veracyte, Inc. future price: according to them, VCYT price has a max estimate of 37.00 USD and a min estimate of 21.00 USD. Read a more detailed Veracyte, Inc. forecast: see what analysts think of Veracyte, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Veracyte, Inc. EBITDA is 17.55 M USD, and current EBITDA margin is 4.19%. See more stats in Veracyte, Inc. financial statements.